Chase S. Hall, M.D.
Associate Professor, Pulmonary, Critical Care and Sleep Medicine
Associate Director Interstitial Lung Disease and Rare Lung Disease Clinic, Interstitial Lung Disease and Rare Lung Disease Clinic, Interstitial Lung Disease and Rare Lung Disease Clinic, SOM-Kansas City
Professional Background
Dr. Chase S. Hall is an Associate Professor of Medicine at the University of Kansas Medical Center in the Division of Pulmonary and Critical Care. He specializes in interstitial and rare lung diseases.
Dr. Hall received his medical degree from the University of Kansas School of Medicine. He completed his residency training in Internal Medicine and at Washington University School of Medicine in St. Louis. He remained at Washington University for his fellowship in Pulmonary and Critical Care and completed a post-doctoral research fellowship in Dr. Castro's Lab.
Education and Training
- BS, Life Sciences, Kansas State University, Manhattan, Kansas
- MD, Medicine, University of Kansas Medical Center, Kansas City, Kansas
- Residency, Internal Medicine, Washington University / Barnes Jewish Hospital, St. Louis, Missouri
- Clinical Fellowship, Pulmonary and Critical Care, Washington University / Barnes Jewish Hospital, St. Louis, Missouri
- Post Doctoral Fellowship, Pulmonary and Critical Care, Washington University / Barnes Jewish Hospital, St. Louis, Missouri
Licensure, Accreditations & Certifications
- Diplomate, American Board of Internal Medicine, ABIM
- Diplomate, American Board of Internal Medicine, Critical Care Medicine , ABIM
- Diplomate, American Board of Internal Medicine, Pulmonary Diseases, ABIM
- Kansas Medical License, Kansas Board of Healing Arts
- Missouri Medical License, Missouri Board of Healing Arts
Professional Affiliations
- 129Xe MRI Clinical Trials Consortium, Member, 2021 - Present
- American College of Chest Physicians, Member, 2018 - Present
- European Respiratory Society, Member, 2018 - Present
- American Thoracic Society, Member, 2014 - Present
Research
Overview
My fellowship research experience included 2.5 years of post-doctoral research training in the Asthma and Airway Translational Research Unit (AATRU) under the mentorship of Dr. Mario Castro. My research focus has been in establishing imaging biomarkers in respiratory disease, with a historical focus in airway and interstitial lung diseases. We utilize both volumetric computed chest tomography (CT) and 129Xe lung MRI.
Currently, we are utilizing the unique properties of 129Xe MRI to develop sensitive imaging biomarkers of treatment response in a number of respiratory diseases. We have focused on protocol development to speed up image acquisition time as well as develop fully automated image analysis programs. Our image analysis pipelines of both CT and 129Xe MRI integrate image segmentation using convolutional neural networks to improve accuracy and reduce time.
We are a member of the 129Xe MRI Clinical Trials Consortium.
https://cpir.cchmc.org/XeMRICTC
Current Research and Grants
- BEGIN Novel ImagiNG Biomarkers (BEGINNING), Cystic Fibrosis Foundation, Co-I, Co-I